Tag

Amicus Pharmaceuticals

1 article

BioMarin Q1 2026 EPS Beats, Stock -1.5%

BioMarin reported Q1 2026 EPS of $0.76 versus $0.74 forecast and revenue $766 million versus $755.94 million expected. Despite beating forecasts, after‑hours stock fell 1.52% to $53.24, trading near i